Literature DB >> 25413261

Aggressive posterior retinopathy of prematurity: a pilot study of quantitative analysis of vascular features.

Rany Woo1, R V Paul Chan, Anand Vinekar, Michael F Chiang.   

Abstract

PURPOSE: To evaluate aggressive posterior retinopathy of prematurity (AP-ROP) with regard to inter-expert diagnostic agreement and quantitative vascular features.
METHODS: Eight ROP experts interpreted 15 retinal images for AP-ROP and plus disease. Inter-expert agreement was calculated by absolute agreement for AP-ROP and plus, and kappa statistic for each expert was compared with others. Retinal vessels were analyzed by a computer-based system to calculate diameter and integrated curvature (IC). Consensus reference standards for images were developed, and quantitative parameters for arterioles and venules were compared among images with AP-ROP vs. not AP-ROP, plus vs. not plus, and AP-ROP vs. plus.
RESULTS: Mean kappa for each expert in AP-ROP diagnosis ranged from -0.15 (no agreement) to 0.42 (moderate agreement). Nine (30 %) of 30 total AP-ROP diagnoses were also classified as not plus disease. Analysis of images with AP-ROP vs. plus showed that images with AP-ROP had higher venular IC (p = 0.04). Arteriolar IC was statistically significant between images with AP-ROP vs. not AP-ROP (p = 0.01) and plus vs. not plus (p = 0.00003). There were no statistically significant differences in diameter between image groups.
CONCLUSIONS: Inter-expert agreement with regard to AP-ROP diagnosis is imperfect. Venular curvature may be a distinguishing characteristic between AP-ROP and plus. Future studies involving quantitative features of AP-ROP will have benefits for clinical diagnosis and management.

Entities:  

Mesh:

Year:  2014        PMID: 25413261     DOI: 10.1007/s00417-014-2857-2

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  28 in total

1.  Retinal vascular tree morphology: a semi-automatic quantification.

Authors:  M Elena Martinez-Perez; Alun D Hughes; Alice V Stanton; Simon A Thom; Neil Chapman; Anil A Bharath; Kim H Parker
Journal:  IEEE Trans Biomed Eng       Date:  2002-08       Impact factor: 4.538

Review 2.  The International Classification of Retinopathy of Prematurity revisited.

Authors: 
Journal:  Arch Ophthalmol       Date:  2005-07

3.  A pilot study using "ROPtool" to quantify plus disease in retinopathy of prematurity.

Authors:  David K Wallace; Zheen Zhao; Sharon F Freedman
Journal:  J AAPOS       Date:  2007-05-29       Impact factor: 1.220

4.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

5.  Computerized analysis of retinal vessel width and tortuosity in premature infants.

Authors:  Clare M Wilson; Kenneth D Cocker; Merrick J Moseley; Carl Paterson; Simon T Clay; William E Schulenburg; Monte D Mills; Anna L Ells; Kim H Parker; Graham E Quinn; Alistair R Fielder; Jeffrey Ng
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-11       Impact factor: 4.799

6.  Semiautomated digital image analysis of posterior pole vessels in retinopathy of prematurity.

Authors:  Deepika N Shah; Clare M Wilson; Gui-shuang Ying; Karen A Karp; Alistair R Fielder; Jeffrey Ng; Monte D Mills; Graham E Quinn
Journal:  J AAPOS       Date:  2009-10       Impact factor: 1.220

7.  15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity.

Authors:  Earl A Palmer; Robert J Hardy; Velma Dobson; Dale L Phelps; Graham E Quinn; C Gail Summers; Carol P Krom; Betty Tung
Journal:  Arch Ophthalmol       Date:  2005-03

8.  Accuracy of retinopathy of prematurity diagnosis by retinal fellows.

Authors:  R V Paul Chan; Steven L Williams; Yoshihiro Yonekawa; David J Weissgold; Thomas C Lee; Michael F Chiang
Journal:  Retina       Date:  2010-06       Impact factor: 4.256

9.  The rate of change in retinal vessel width and tortuosity in eyes at risk for retinopathy of prematurity.

Authors:  Devon H Ghodasra; Atiporn Thuangtong; Karen A Karp; Gui-Shuang Ying; Monte D Mills; Clare A Wilson; Alistair R Fielder; Jeffery Ng; Graham E Quinn
Journal:  J AAPOS       Date:  2012-10       Impact factor: 1.220

Review 10.  Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010.

Authors:  Hannah Blencowe; Joy E Lawn; Thomas Vazquez; Alistair Fielder; Clare Gilbert
Journal:  Pediatr Res       Date:  2013-12       Impact factor: 3.756

View more
  5 in total

1.  Experts contradict established classification.

Authors:  Michael J Shapiro; Michael P Blair; Jose M Garcia-Gonzalez
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-07-21       Impact factor: 3.117

2.  Science and art in retinopathy of prematurity diagnosis.

Authors:  Michael F Chiang; R V Paul Chan; Anand Vinekar; Rany Woo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-07-22       Impact factor: 3.117

3.  The Global Education Network for Retinopathy of Prematurity (Gen-Rop): Development, Implementation, and Evaluation of A Novel Tele-Education System (An American Ophthalmological Society Thesis).

Authors:  R V Paul Chan; Samir N Patel; Michael C Ryan; Karyn E Jonas; Susan Ostmo; Alexander D Port; Grace I Sun; Andreas K Lauer; Michael F Chiang
Journal:  Trans Am Ophthalmol Soc       Date:  2015

4.  Need for Refinement of International Retinopathy of Prematurity Guidelines and Classifications.

Authors:  Ramak Roohipoor; John I Loewenstein
Journal:  J Ophthalmic Vis Res       Date:  2015 Oct-Dec

Review 5.  Artificial Intelligence in Retinopathy of Prematurity Diagnosis.

Authors:  Brittni A Scruggs; R V Paul Chan; Jayashree Kalpathy-Cramer; Michael F Chiang; J Peter Campbell
Journal:  Transl Vis Sci Technol       Date:  2020-02-10       Impact factor: 3.283

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.